Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
8-K
Exec departure
confidence 92%
filed 2026-06-05
Item 5.02
Theresa Greco, Chief Commercial Officer, is departing OptimizeRx Corporation effective June 15, 2026, pursuant to a separation agreement executed June 1, 2026. While the filing also discloses severance and advisory arrangement terms, the principal disclosed action is the departure of a named executive officer from her role, making exec_departure the most salient classification. The departure of a CCO is material to investors' assessment of the company's commercial leadership and strategy.
View raw filing on EDGAR →
8-K
Exec departure
confidence 95%
filed 2026-06-05
Item 5.02
Eric Haynor, the Chief Operating Officer, resigned effective June 5, 2026. The filing explicitly states his resignation and confirms it was not due to disagreement with the Company. This is a departure of a named executive officer and would materially affect investor assessment of the registrant's leadership and operational continuity.
View raw filing on EDGAR →
8-K
Exec departure
confidence 95%
filed 2026-06-05
Henry Liu resigned as Co-Chief Executive Officer effective June 2, 2026, with no disagreement cited. The filing discloses under Item 5.02 that following his departure, Yang Li now serves as sole CEO. This is a material executive departure affecting the company's leadership structure.
View raw filing on EDGAR →
8-K
Exec departure
confidence 95%
filed 2026-06-05
Item 5.02
The filing discloses the resignation of two senior executives effective immediately: Christopher J. Porcelli (General Counsel, Chief People Officer, and Corporate Secretary) and Brian Brady (non-executive Chairman and Board member). These are material departures of named officers and a director that would affect investor assessment of the company's governance and leadership continuity. The immediate effective date and lack of transition details heighten materiality.
View raw filing on EDGAR →
8-K
Exec departure
confidence 95%
filed 2026-06-05
Item 5.02
Alka Chaubey, Ph.D., Chief Medical Officer of Bionano Genomics, resigned effective July 5, 2026. This is a clear departure of a named executive officer disclosed under Item 5.02, and the departure of a CMO—a senior leadership position—is material to investors' assessment of the company's medical and scientific direction.
View raw filing on EDGAR →
8-K
Exec departure
confidence 95%
filed 2026-06-05
Wilfred Daye resigned as both a director and Chief Strategy Officer of Chaince Digital Holdings Inc., effective immediately on June 3, 2026. This is a clear executive departure under Item 5.02, involving the loss of a senior officer and board member. The filing explicitly states the resignation was voluntary and not due to disagreement, but the departure of a C-suite executive and director is material to investors assessing the company's leadership and governance.
View raw filing on EDGAR →
8-K
Exec departure
confidence 95%
filed 2026-06-05
The filing discloses the resignation of two directors (David E. Lazar and Avraham Ben-Tzvi, effective June 5, 2026) and the Chief Operating Officer (Walt A. Linscott, effective June 1, 2026). While Linscott transitions to a consulting role, the primary disclosed action is the departure of these executives from their positions. The filing explicitly states these resignations were not due to disagreement, but the simultaneous departure of multiple board members and a C-suite officer is material to investors assessing governance and leadership continuity.
View raw filing on EDGAR →
8-K
Exec departure
confidence 75%
filed 2026-06-05
Item 5.02
DeEtte Gray, President of U.S. Operations, notified the Company on June 1, 2026 of her intention to retire effective June 30, 2026. While the disclosure also details a transition agreement with compensatory terms for a post-retirement advisory role through December 31, 2026, the principal disclosed action is the departure of a named executive officer from her operational role. The retirement of a President-level executive is material to investors assessing management continuity and operational leadership.
View raw filing on EDGAR →
8-K
Exec departure
confidence 94%
filed 2026-06-05
Item 5.02
Jared Stanley resigned from his position as a member of the Board of Directors effective June 3, 2026, though he will continue in an advisory capacity. The departure was announced via press release on June 5, 2026 and does not relate to any disagreement with the company.
View raw filing on EDGAR →
8-K
Exec departure
confidence 93%
filed 2026-06-04
Item 5.02
David B. Foss, Chair of the Board and former CEO (2016–2024), notified the Board on May 29, 2026 of his intent to retire from his director role effective July 15, 2026. The filing discloses this material departure of a senior executive and long-tenured board leader through Item 5.02(b) and a Regulation FD disclosure with accompanying press release.
View raw filing on EDGAR →
8-K
Exec departure
confidence 75%
filed 2026-06-04
Item 5.02
Vincent Fazio's retirement as Executive Vice President and Chief Financial Officer effective June 30, 2026, is the principal disclosed action. While the filing also covers the appointment of Angela Krezmer as his successor and Angelo Testani as Executive Vice President and Chief Banking Officer, the departure of the CFO is the most salient event. The filing centers on Fazio's departure notification on May 29, 2026, and the related Retirement and Consulting Agreement, making this a material executive departure.
View raw filing on EDGAR →
8-K
Exec departure
confidence 95%
filed 2026-06-04
Item 5.02
David L. Duvall's resignation from the Board effective June 1, 2026, is disclosed as related to his previously announced retirement as President & Chief Executive Officer. The departure of a CEO from both executive and board roles is a material event affecting investor assessment of company leadership and governance. The explicit statement that the resignation was "not due to any disagreement" mitigates concerns but does not diminish materiality.
View raw filing on EDGAR →
8-K
Exec departure
confidence 95%
filed 2026-06-04
Item 5.02
Kavita Mahtani, a Class I director and member of the Audit Committee and Strategy & Financing Committee, notified the Company of her resignation from the Board effective June 11, 2026. The disclosure centers on her departure from the Board, which is a material executive departure given her committee memberships and tenure since April 2022.
View raw filing on EDGAR →
8-K
Exec departure
confidence 95%
filed 2026-06-04
Item 5.02
Mark J. Hall, a director on Monster Beverage's Board, provided notice of his intention to resign as a director effective August 1, 2026, and as an employee of the Company's subsidiary effective April 1, 2027. The filing centers on the departure of a named executive and director, with no appointment of a replacement disclosed. The resignation is material as it reduces Board size and affects the composition of the Company's governance.
View raw filing on EDGAR →
8-K
Exec departure
confidence 95%
filed 2026-06-04
Item 5.02
Cindy Tang, the Company's CFO, resigned effective May 29, 2026. The resignation was formalized through a Separation Agreement disclosed under Item 1.01, and the CEO is temporarily assuming CFO duties pending a search for a replacement.
View raw filing on EDGAR →
8-K
Exec departure
confidence 95%
filed 2026-06-04
Item 5.02
Kathryn Gregory's resignation from the Board of Directors effective June 1, 2026 is a clear executive departure. The filing explicitly states her resignation and the effective date, with a standard disclaimer that it was not due to disagreement. Board departures are material events affecting the composition of the registrant's governance and oversight structure.
View raw filing on EDGAR →
8-K
Exec departure
confidence 75%
filed 2026-06-04
Item 5.02
Michael L. Perkins, Senior Executive Vice President and Chief Risk Officer, is retiring effective June 30, 2026. While the filing also discloses a consulting arrangement with compensation terms, the principal disclosed action is the departure of a named executive from his officer role. The retirement of a C-suite executive responsible for risk oversight is material to investors' assessment of the company's governance and risk management continuity.
View raw filing on EDGAR →
8-K
Exec departure
confidence 75%
filed 2026-06-04
Item 5.02
Mr. Nicholas Maestas resigned as Chief Financial Officer and Principal Financial Officer effective June 5, 2026, affecting the registrant's financial leadership.
View raw filing on EDGAR →
8-K
Exec departure
confidence 95%
filed 2026-06-04
Item 5.02
Yilin Lu resigned from his position as President and Board member of LQR House Inc., effective immediately on June 4, 2026. This is a clear executive departure involving loss of both an officer role and board seat, which materially affects the company's leadership structure and governance. The filing explicitly states the resignation was not due to disagreement, but the departure itself is material to investors assessing management continuity.
View raw filing on EDGAR →
8-K
Exec departure
confidence 90%
filed 2026-06-04
Item 5.02
Kevin Knight resigned as Executive Chairman and Board member effective June 3, 2026. The filing also discloses the appointment of David Vander Ploeg as Chair and a $20.25 million retirement payment and consulting agreement ancillary to Knight's departure.
View raw filing on EDGAR →
8-K
Exec departure
confidence 75%
filed 2026-06-03
Item 5.02
Andi R. Owen departed as President and CEO effective June 30, 2026, following her resignation from the Board and officer positions on May 30, 2026. The filing discloses severance terms including 18 months of base salary and health benefits continuation.
View raw filing on EDGAR →
8-K
Exec departure
confidence 92%
filed 2026-06-03
Item 7.01
Doug Woolley, executive vice president and chief credit officer, announced his planned retirement effective April 1, 2027. As a named executive officer responsible for credit operations at a bank, his departure is material to investors' assessment of management continuity and credit risk oversight. The disclosure centers on the departure event, not the successor appointment.
View raw filing on EDGAR →
8-K
Exec departure
confidence 75%
filed 2026-06-03
Item 5.02
David Gansberg stepped down from his role as President of Arch Capital Group effective immediately, departing the Company following a distinguished tenure. Maamoun Rajeh assumed expanded responsibilities as President. The departure of this senior executive overseeing the Global Insurance Group is material to investors.
View raw filing on EDGAR →
8-K
Exec departure
confidence 92%
filed 2026-06-03
Item 5.02
Two directors, Gianmaria C. Delzanno and Deborah A. DeCotis, departed the board at the 2026 Annual Meeting held on May 29, 2026, as their terms expired and they were not nominated for re-election.
View raw filing on EDGAR →
8-K
Exec departure
confidence 92%
filed 2026-06-03
Item 5.02
Andrew Del Matto, Chief Financial Officer, announced his retirement effective upon the start of a successor, with the company conducting a search and Del Matto remaining during the transition period.
View raw filing on EDGAR →
8-K
Exec departure
confidence 92%
filed 2026-06-03
Item 5.02
Four directors—Ronald G. Lehman II, Richard E. Turk, Jessica Maher, and Robert M. Carrino—resigned from the board effective at the Effective Time of the merger, with the company noting the resignations were not due to any disagreement.
View raw filing on EDGAR →
8-K
Exec departure
confidence 75%
filed 2026-06-03
Item 5.02
Matthew K. Szot departed as Chief Financial Officer effective May 28, 2026, following a mutual agreement with the Company. While the filing also discloses the interim appointment of Quang X. Pham as interim CFO and severance arrangements totaling approximately $603,709 in cash and accelerated equity vesting, the principal disclosed action centers on Szot's departure. The departure of a CFO is material to investors assessing financial reporting oversight and continuity.
View raw filing on EDGAR →
8-K
Exec departure
confidence 95%
filed 2026-06-03
The filing discloses the departure of Jaret Christopher as Chief Executive Officer and director of SpringBig Holdings, Inc., effective May 28, 2026. The Separation Agreement specifies severance terms including two months of base salary continuation, COBRA premiums, and a $50,000 cash payment. The departure of a CEO is material to investors as it affects corporate leadership and governance.
View raw filing on EDGAR →
8-K
Exec departure
confidence 85%
filed 2026-06-03
Item 5.02
Marshall S. McCrea III, Co-Chief Executive Officer of Energy Transfer LP, notified the Partnership on June 1, 2026 of his intention to retire effective on or before December 31, 2026. While the filing also discloses compensatory arrangements (acceleration of equity awards and a separation agreement), the principal disclosed action is McCrea's departure from the Co-CEO role, with Thomas E. Long assuming sole CEO responsibilities. This is material as it involves a change in executive leadership at a major energy partnership.
View raw filing on EDGAR →
8-K
Exec departure
confidence 92%
filed 2026-06-03
Item 7.01
The filing discloses Mr. Wright's resignation via press release issued on June 3, 2026. Although disclosed under Item 7.01 (Regulation FD Disclosure) rather than the typical Item 5.02, the substance is clearly an executive departure. The resignation of a named executive is material to investors' assessment of the company's leadership and governance.
View raw filing on EDGAR →
8-K
Exec departure
confidence 92%
filed 2026-06-03
Item 5.02
Raphael Thomas Wallander resigned as a Class III director and member of the Human Capital Management and Compensation Committee on May 28, 2026. The principal disclosed action is a director's departure from the board, which is material to investors as it affects board composition and governance. The context of his recent appointment in October 2025 in connection with a debt exchange transaction adds significance to the departure.
View raw filing on EDGAR →
8-K
Exec departure
confidence 75%
filed 2026-06-02
Item 5.02
Tracy Skeans is transitioning from her roles as Chief Operating Officer and Chief People & Culture Officer effective November 1, 2026, with retirement expected March 1, 2028. While the disclosure includes compensatory arrangements (base salary continuation, bonus eligibility, $500,000 lump sum payment, and equity vesting), the principal disclosed action is the departure of a senior executive from material operational roles. The departure of a COO is material to investors assessing management continuity and operational leadership.
View raw filing on EDGAR →
8-K
Exec departure
confidence 95%
filed 2026-06-02
Item 5.02
Belvin Williamson, Jr. notified the company on May 28, 2026 of his resignation from the board of directors, effective July 28, 2026. This is a clear departure of a director, which is material to investors as board composition affects governance and oversight. The disclosure is straightforward and unambiguous.
View raw filing on EDGAR →
8-K
Exec departure
confidence 95%
filed 2026-06-02
Item 5.02
Philippe Busque, Ph.D., Senior Vice President of Global Sales and Services, resigned effective June 5, 2026, to pursue another career opportunity. The disclosure centers on the departure of a named executive officer from a material sales and services leadership role. While the resignation is stated as non-contentious, the loss of an SVP responsible for global sales represents a material change in executive composition that would affect investor assessment of the company's operational continuity.
View raw filing on EDGAR →
8-K
Exec departure
confidence 75%
filed 2026-06-02
Item 5.02
David S. Schulz, Executive Vice President and Chief Financial Officer, retired from the Company effective May 31, 2026, after serving in the role through February 16, 2026. The filing also discloses a post-retirement consulting arrangement.
View raw filing on EDGAR →
8-K
Exec departure
confidence 95%
filed 2026-06-02
Item 5.02
Zaneta Koplewicz resigned from her positions as Co-President, Head of Shareholder Relations, and Board member, effective June 24, 2026. The disclosure centers on her departure from multiple senior executive and board roles, making this a clear executive departure event. The resignation of a Co-President and board director is material to investors' assessment of the company's leadership and governance.
View raw filing on EDGAR →
8-K
Exec departure
confidence 75%
filed 2026-06-02
Item 5.02
Bret Christensen resigned as Chief Executive Officer of BioTE, effective June 8, 2026. Robert Peterson was appointed as Interim CEO and Marc Beer as Executive Chairman in connection with the departure.
View raw filing on EDGAR →
8-K
Exec departure
confidence 72%
filed 2026-06-02
Item 5.02
Jan Vleugals, Chief Operating Officer International, provided notice of retirement effective September 30, 2026, after more than a decade of service. Bob Calver will assume the role effective October 1, 2026.
View raw filing on EDGAR →
8-K
Exec departure
confidence 95%
filed 2026-06-02
Item 5.02
Ron E. Jackson retired from the Board of Trustees of Pebblebrook Hotel Trust, effective May 29, 2026 at the Annual Meeting, reducing the board size from eight to seven trustees.
View raw filing on EDGAR →
8-K
Exec departure
confidence 92%
filed 2026-06-01
Item 5.02
Two directors, Ms. Laurie J. Thomsen and Mr. Luis Avila-Marco, retired from the Board effective at the conclusion of the 2026 Annual Meeting held on May 28, 2026. One retirement was pursuant to mandatory retirement policy and the other by voluntary non-reelection, with no disagreements disclosed.
View raw filing on EDGAR →
8-K
Exec departure
confidence 75%
filed 2026-06-01
William Turner, Executive Vice President and Chief Credit Officer of U.S. Century Bank, notified the Company of his decision to retire effective July 3, 2026. While the filing also announces Sergio Garrido's appointment as successor, the principal disclosed action centers on Turner's departure. The Chief Credit Officer role is material to a financial institution's risk management and governance, making this departure material to investors.
View raw filing on EDGAR →
8-K
Exec departure
confidence 95%
filed 2026-06-01
Item 5.02
Stephen E. Gorman resigned from the Board of Directors of FedEx Corp and John A. Smith departed from his position as Chief Operating Officer, United States and Canada, both effective immediately prior to the Spin-Off Effective Time on June 1, 2026. While both executives transitioned to roles at FedEx Freight, their departures from FedEx Corp represent a material change in leadership.
View raw filing on EDGAR →
8-K
Exec departure
confidence 85%
filed 2026-06-01
Item 5.02
Michael Hebert resigned from his position as Senior Vice President of People effective May 31, 2026. While the disclosure includes severance terms ($137,500 plus COBRA coverage), the principal disclosed action is the departure of a named executive officer. The resignation is material as it affects the registrant's executive leadership and operational continuity, though the company notes the departure was not due to disagreement on operational matters.
View raw filing on EDGAR →
8-K
Exec departure
confidence 75%
filed 2026-06-01
Item 5.02
Thomas Liguori, the former Executive Vice President and Chief Financial Officer and Corporate Secretary, has communicated his intent to retire and entered into a separation and release agreement effective May 26, 2026, with employment ending December 26, 2026. While the filing also references John Schwietz's prior appointment as successor CFO (April 8, 2026), the principal disclosed action in this Item 5.02 section is Liguori's departure—his retirement, separation terms, and severance arrangements. The detailed severance package (20 weeks base salary plus service-based weeks, accelerated vesting, and incentive payouts) underscores the materiality of the CFO's departure.
View raw filing on EDGAR →
8-K
Exec departure
confidence 92%
filed 2026-06-01
Item 5.02
Srinivas Attili, Executive Vice President of the Civilian Business Group, stepped down from his role effective May 29, 2026 and will depart the Company on or about June 12, 2026. While the disclosure mentions severance compensation, the principal disclosed action is the departure of a named executive officer from the Company, making this an exec_departure event. The departure of an EVP responsible for a major business segment is material to investors.
View raw filing on EDGAR →
8-K
Exec departure
confidence 85%
filed 2026-06-01
Item 5.02
The principal disclosed action is the resignation of Tawn Kelley as Chair and Board member, effective immediately on May 31, 2026. While the filing also mentions the appointment of Michael Berman as Chair and Gary Robinette to the Nominating and Governance Committee, the central event is Kelley's departure from the Board. The resignation of a Chair is material to investors as it affects corporate governance and leadership structure.
View raw filing on EDGAR →
8-K
Exec departure
confidence 95%
filed 2026-06-01
Item 5.02
Edward V. Weller, the Chief Financial Officer and a named executive officer identified in the Bank's 10-K, has notified the Bank of his intent to retire effective October 20, 2026. The disclosure centers on the departure of a senior executive officer, making this an exec_departure event. The CFO role is material to investors' assessment of the registrant's financial management and governance.
View raw filing on EDGAR →
8-K
Exec departure
confidence 95%
filed 2026-06-01
Item 5.02
Hans-Juergen Woerle, M.D., Ph.D. resigned from his position as a board member of Seres Therapeutics effective May 31, 2026. The disclosure explicitly states the departure and its effective date, with a standard representation that the resignation was not due to disagreement. Board departures are material events affecting the composition of the company's governance.
View raw filing on EDGAR →
8-K
Exec departure
confidence 75%
filed 2026-06-01
Item 5.02
Amro Albanna resigned as Chief Executive Officer and Director, Shahrokh Shabahang resigned as Director, and Rowena Albanna resigned as Chief Operating Officer. Jeffrey M. Busch was appointed as Interim CEO and Brian Brady as Chairman.
View raw filing on EDGAR →
8-K
Exec departure
confidence 95%
filed 2026-06-01
Item 5.02
Kenneth Brimmer resigned effective May 26, 2026, from his positions as Board member and Chief Financial Officer, serving simultaneously as principal financial officer and principal accounting officer. The departure of a CFO and principal accounting officer is material to investors' assessment of financial reporting oversight and governance. The filing explicitly states no successor has yet been appointed, creating a temporary gap in critical financial leadership roles.
View raw filing on EDGAR →